Martin Murphy Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Exits
  • 1

Exits

Martin Murphy General Information

Description

Dr. Martin Murphy is a Co-Founder and serves as Chief Executive Officer at Syncona. He served as Board Member at Neogene Therapeutics and Cambridge Epigenetix. He serves as the Chairman at Anaveon, Azeria Therapeutics, and Quell Therapeutics. He served as Project Manager at Cambridge Consultants. He serves as a Board Member of Resolution Therapeutics and Achilles Therapeutics. He is the Chairman of Blue Earth Diagnostics.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 2nd Floor
  • 8 Bloomsbury Street
  • London WC1B 3SR
  • England, United Kingdom
+44 020 0000 0000

Martin Murphy Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000 00000000 15-Sep-2015 00000 00000 00.000 Biotechnology Generating Revenue 000000 000000 00.0
To view Martin Murphy’s complete investments history, request access »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Martin Murphy Exits (1)

Company Name Exit Date Exit Type Exit Size
0000000 00000000 01-Jun-2018 000000000000000000
To view Martin Murphy’s complete exits history, request access »

Martin Murphy Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Martin Murphy Team (1)

Name Title Deals Funds Boards Office
Martin Murphy Ph.D Angel Investor 00 0 0 London, United Kingdom
To view Martin Murphy’s complete team members history, request access »